Stephen Hoffman
Equibles does not estimate personal net worth.
Get an email with a short summary when Whitehawk Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get WHWK alertsAbout Stephen Hoffman
Stephen Hoffman is recorded as CEO at Whitehawk Therapeutics, Inc. (WHWK). The proxy statement of Whitehawk Therapeutics, Inc. reports total compensation of $2,088,701 for Stephen Hoffman in fiscal 2019, including a base salary of $393,506. Disclosed compensation is on record for 2 fiscal years. Whitehawk Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Whitehawk Therapeutics, Inc. includes Brendan Delaney (CEO, COO and Board Member), David J. Lennon (CEO and Board Member), David Lennon (CEO and Board Member) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at Whitehawk Therapeutics, Inc.
- Brendan Delaney CEO, COO, Board Member
- David J. Lennon CEO, Board Member
- David Lennon CEO, Board Member
- Neil Desai, Ph.D. CEO, Board Member
- Caley Castelein, M.D. Chairman
- Neil Desai Chairman, Board Member
- Lance Thibault CFO
- Scott Giacobello CFO, Chief Accounting Officer
- Anupam Dalal Board Member
- Anupam Dalal, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Whitehawk Therapeutics, Inc. (WHWK) | Former Chief Executive Officer | $393,506 | $2,088,701 |
| 2018 | Whitehawk Therapeutics, Inc. (WHWK) | Former Chief Executive Officer | $470,000 | $1,443,164 |
Recent activity
No call appearances or filed executive changes recorded yet.